PURPOSE: This prospective cohort study examined clinical outcomes of low vision rehabilitation (LVR) delivered by a mobile clinic. METHODS: Participants were recruited from those scheduled for mobile clinic LVR and met the United States definition of legal blindness. Participants completed the Massof Activity Inventory (AI) before LVR, 3 months post-LVR, and 1 year post-LVR. Change scores and measures of clinical effect (i.e. Cohen's effect size and minimum clinically important difference, MCID) were calculated for each time point and compared. Additional participant characteristics (age, acuity, contrast sensitivity, cause of visual impairment, training recommendations, and prior LVR experience) were also explored with respect to outcome measures. RESULTS: Of the 66 participants enroled in this study, 47% had no prior LVR experience. Significant differences were noted between baseline and 3-month person measures, and between baseline and 1-year person measures. There was no significant difference between 3-month and 1-year person measures, nor was there a significant difference in change score between these two time points. At 1 year post-LVR, overall visual ability effect size was 0.74. A clinically meaningful outcome was achieved in 56% of participants at 3 months and 71% at 1 year for overall visual ability. There was no significant difference in the proportion of participants achieving MCID at 3 months vs 1 year. Of participants who completed the 1-year post-LVR AI, 59% reported a subjective worsening of vision during the study period. This subgroup also tended to have smaller 1-year change scores. CONCLUSIONS: Mobile clinic LVR is effective at expanding access to care and produces clinically meaningful outcomes comparable to those seen in other outpatient LVR delivery models.
PURPOSE: This prospective cohort study examined clinical outcomes of low vision rehabilitation (LVR) delivered by a mobile clinic. METHODS:Participants were recruited from those scheduled for mobile clinic LVR and met the United States definition of legal blindness. Participants completed the Massof Activity Inventory (AI) before LVR, 3 months post-LVR, and 1 year post-LVR. Change scores and measures of clinical effect (i.e. Cohen's effect size and minimum clinically important difference, MCID) were calculated for each time point and compared. Additional participant characteristics (age, acuity, contrast sensitivity, cause of visual impairment, training recommendations, and prior LVR experience) were also explored with respect to outcome measures. RESULTS: Of the 66 participants enroled in this study, 47% had no prior LVR experience. Significant differences were noted between baseline and 3-month person measures, and between baseline and 1-year person measures. There was no significant difference between 3-month and 1-year person measures, nor was there a significant difference in change score between these two time points. At 1 year post-LVR, overall visual ability effect size was 0.74. A clinically meaningful outcome was achieved in 56% of participants at 3 months and 71% at 1 year for overall visual ability. There was no significant difference in the proportion of participants achieving MCID at 3 months vs 1 year. Of participants who completed the 1-year post-LVR AI, 59% reported a subjective worsening of vision during the study period. This subgroup also tended to have smaller 1-year change scores. CONCLUSIONS: Mobile clinic LVR is effective at expanding access to care and produces clinically meaningful outcomes comparable to those seen in other outpatient LVR delivery models.